Thursday, October 20, 2016
6:00 PM PT – Registration
6:30 PM PT – Presentation

Walter's Restaurant 310 Yale Ave. Claremont California

Marjan Farid, MD
Director of Cornea, Cataract and Refractive Surgery,
University of California Irvine, Irvine, CA

REGISTER NOW or call 1-800-952-0907

Link to handout

XiidraTM (li tegrast ophthalmic solution) 5% is indicated for the treatment of signs and symptoms of dry eye disease (DED).

Important Safety Information
  • In clinical trials, the most common adverse reactions reported in 5-25 % of patients were instillation site irritation, dysgeusia and reduced visual acuity. Other adverse reactions reported in 1% to 5% of the patients were blurred vision, conjunctival hyperemia, eye irritation, headache, increased lacrimation, eye discharge, eye discomfort, eye pruritus and sinusitis.
  • To avoid the potential for eye injury or contamination of the solution, patients should not touch the tip of the single-use container to their eye or to any surface.
  • Contact lenses should be removed prior to the administration of Xiidra and may be reinserted 15 minutes following administration.
  • Safety and efficacy in pediatric patients below the age of 17 years have not been established. If you are a licensed eye care professional, your NPI and/or State License Number is required for program registration. This program is intended for U.S. healthcare providers only. Guests and spouses may not attend this program. A meal will be provided during this educational program. In accordance with the Federal Physician Payment Sunshine Statute and any applicable state reporting laws, the value of the food and beverage provided and your national provider identity will be disclosed to CMS and any applicable state agencies and posted on the Shire Corporate website.